Patients receive incomplete chronic medicine supplies at several KZN hospitals
Patients at several KwaZulu-Natal public hospitals say they received only some—or none—of their chronic medication, while the provincial health department attributes the disruption to national and international supply-chain pressures.
Several hospitals in KwaZulu-Natal (KZN) are facing issues with patients receiving incomplete chronic medicine supplies, according to the KZN Department of Health. The shortages are attributed to disruptions in international trade, geopolitical conflicts, global economic pressures, and challenges with raw materials and active pharmaceutical ingredients used to manufacture medicines. Penny Msimango, the head of the department, acknowledged that the problem is part of a broader national and international supply challenge.
The Democratic Alliance (DA) claims that the shortages include essential medicines for treating high blood pressure, high cholesterol, diabetes, and schizophrenia. In response to the issue, the KZN Department of Health has intensified efforts to minimize the impact on patients. These efforts include inspections at clinics and hospitals, moving available medicines between facilities, sourcing medicines outside existing contractual arrangements, providing alternative medicines, and issuing shorter supplies in some cases.
Patients have shared their experiences of struggling with the shortages. A 67-year-old woman from South Beach, who requires medications for high blood pressure, cholesterol, and sinus issues, had to buy her medications at a pharmacy at her expense due to the lack of supply at the hospital. She resorted to using a lower dosage of her sinus medication when it was not as effective.
Similarly, a 52-year-old woman from Phoenix faces short medication supplies every month, sometimes receiving only half a box instead of her usual four-month supply.
Written by urgent.news from IOL's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.